Screening
Screening for lymphedema following a diagnosis of cancer, and associated treatment, has been advocated based on expert opinion, with the aim of initiating early treatment in this high-risk group.[12] Prospective surveillance models have been developed and are utilized at some cancer treatment centers with the aim of early detection and treatment of lymphedema; this involves a preoperative assessment measuring baseline limb volume and functional mobility, which can then be compared with postoperative results tracked regularly over time.[47] It is important that screening programs account for factors, such as changes in body weight, that may affect interlimb differences.[65]
Screening via genetic testing may be offered to family members of those diagnosed with a gene defect causing lymphedema, following shared decision-making.[2]
Use of this content is subject to our disclaimer